
    
      Study participants will receive a single booster dose of DTcP or a single booster dose of
      local DT in 4 to 6 years old ,a singel booster dose of DTcP or a single booster dose of DTaP
      in 18 to 24 months, three basic doses of DTcP or three doses of DTaP/ DTaP-IPV-Hib in 2 to 6
      months.Safety profile will be assessed in all subjects up to Day 30 post vaccination.
    
  